Evergreen Health, UBMD partner on new HIV trial
Two HIV-positive Buffalo patients will be among the first in the nation to try a new treatment that reduces their medication regimen from daily pills to just once a month.
Access to the injectable medication comes through a clinical trial taking place at Evergreen Health's downtown facility and the University at Buffalo Department of Medicine’s HIV and infectious disease division in conjunction with UBMD Internal Medicine.
It’s part of a broader collaboration b etween Evergreen Health and UBMD…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Tracey Drury Source Type: news
More News: Biotechnology | Clinical Trials | Health Management | Infectious Diseases | Internal Medicine